{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:28:25Z","timestamp":1724891305167},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,27]]},"DOI":"10.7759\/cureus.67983","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T06:49:22Z","timestamp":1724827762000},"source":"Crossref","is-referenced-by-count":0,"title":["Domino Liver Transplantation: Anesthetic Considerations for a Patient With Maple Syrup Urine Disease and Type I Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Colton","family":"Southard-Goebel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo A","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Maple syrup urine disease","author":"Strauss KA","year":"2020","unstructured":"Strauss KA, Puffenberger EG, Carson VJ. Maple syrup urine disease. GeneReviews\u00ae. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington, Seattle, Seattle, WA; 2020."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2020.01.006","article-title":"Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): treatment, biomarkers, and outcomes","volume":"129","author":"Strauss KA","year":"2020","unstructured":"Strauss KA, Carson VJ, Soltys K, et al.. Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): treatment, biomarkers, and outcomes. Mol Genet Metab. 2020, 129:193-206. 10.1016\/j.ymgme.2020.01.006","journal-title":"Mol Genet Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(05)81036-4","article-title":"Cerebral edema causing death in children with maple syrup urine disease","volume":"119","author":"Riviello JJ","year":"1991","unstructured":"Riviello JJ, Rezvani I, DiGeorge AM, Foley CM. Cerebral edema causing death in children with maple syrup urine disease. J Pediatr. 1991, 119:42-5. 10.1016\/s0022-3476(05)81036-4","journal-title":"J Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/BF02072492","article-title":"Intellectual performance of children with maple syrup urine disease","volume":"152","author":"Hilliges C","year":"1993","unstructured":"Hilliges C, Awiszus D, Wendel U. Intellectual performance of children with maple syrup urine disease. Eur J Pediatr. 1993, 152:144-7. 10.1007\/BF02072492","journal-title":"Eur J Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.939893","article-title":"Outcomes from a single transplant center of 5 pediatric cases of domino liver transplantation from live donors with maple syrup urine disease","volume":"28","author":"Zhang JP","year":"2023","unstructured":"Zhang JP, Zhu ZJ, Sun LY, et al.. Outcomes from a single transplant center of 5 pediatric cases of domino liver transplantation from live donors with maple syrup urine disease. Ann Transplant. 2023, 28:e939893. 10.12659\/AOT.939893","journal-title":"Ann Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25423","article-title":"Surgical aspects of liver transplantation and domino liver transplantation in maple syrup urine disease: analysis of 15 donor-recipient pairs","volume":"25","author":"Herden U","year":"2019","unstructured":"Herden U, Grabhorn E, Santer R, et al.. Surgical aspects of liver transplantation and domino liver transplantation in maple syrup urine disease: analysis of 15 donor-recipient pairs. Liver Transpl. 2019, 25:889-900. 10.1002\/lt.25423","journal-title":"Liver Transpl"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4274\/jpr.89421","article-title":"Dietary management of a patient with both maple syrup urine disease and type I diabetes","volume":"21","author":"G\u00fcnd\u00fcz M","year":"2018","unstructured":"G\u00fcnd\u00fcz M, Ko\u00e7 N, \u00dcnal \u00d6, et al.. Dietary management of a patient with both maple syrup urine disease and type I diabetes. J Pediatr Res. 2018, 21:44-6. 10.4274\/jpr.89421","journal-title":"J Pediatr Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15391","article-title":"The Anaesthesia Case Report (ACRE) checklist: a tool to promote high-quality reporting of cases in peri-operative practice","volume":"76","author":"Shelton CL","year":"2021","unstructured":"Shelton CL, Klein AA, Bailey CR, El-Boghdadly K. The Anaesthesia Case Report (ACRE) checklist: a tool to promote high-quality reporting of cases in peri-operative practice. Anaesthesia. 2021, 76:1077-81. 10.1111\/anae.15391","journal-title":"Anaesthesia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-007-9114-3","article-title":"Psychosocial issues in families affected by maple syrup urine disease","volume":"16","author":"Packman W","year":"2007","unstructured":"Packman W, Henderson SL, Mehta I, Ronen R, Danner D, Chesterman B, Packman S. Psychosocial issues in families affected by maple syrup urine disease. J Genet Couns. 2007, 16:799-809. 10.1007\/s10897-007-9114-3","journal-title":"J Genet Couns"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch CJ","year":"2014","unstructured":"Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. 2014, 10:723-36. 10.1038\/nrendo.2014.171","journal-title":"Nat Rev Endocrinol"},{"key":"ref11","unstructured":"Cleveland Clinic. Brittle diabetes. (2023). Accessed: December 4, 2023: https:\/\/my.clevelandclinic.org\/health\/diseases\/21499-brittle-diabetes."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i22.6835","article-title":"Predictive roles of intraoperative blood glucose for post-transplant outcomes in liver transplantation","volume":"21","author":"Park CS","year":"2015","unstructured":"Park CS. Predictive roles of intraoperative blood glucose for post-transplant outcomes in liver transplantation. World J Gastroenterol. 2015, 21:6835-41. 10.3748\/wjg.v21.i22.6835","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2007.02.019","article-title":"Effect of intraoperative hyperglycemia during liver transplantation","volume":"140","author":"Ammori JB","year":"2007","unstructured":"Ammori JB, Sigakis M, Englesbe MJ, O'Reilly M, Pelletier SJ. Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res. 2007, 140:227-33. 10.1016\/j.jss.2007.02.019","journal-title":"J Surg Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0810-z","article-title":"Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3\u00a0months and at 5\u00a0years","volume":"41","author":"Ramos-Prol A","year":"2018","unstructured":"Ramos-Prol A, Herv\u00e1s-Mar\u00edn D, Rodr\u00edguez-Medina B, Rubio-Almanza M, Berenguer M, Moya-Herraiz \u00c1, Merino-Torres JF. Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3\u00a0months and at 5\u00a0years. J Endocrinol Invest. 2018, 41:821-9. 10.1007\/s40618-017-0810-z","journal-title":"J Endocrinol Invest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2019.03.006","article-title":"Three-dimensional volumetric assessment of graft volume in living donor liver transplantation: does it minimise errors of estimation?","volume":"10","author":"Mohapatra N","year":"2020","unstructured":"Mohapatra N, Gurumoorthy Subramanya Bharathy K, Kumar Sinha P, Vasantrao Sasturkar S, Patidar Y, Pamecha V. Three-dimensional volumetric assessment of graft volume in living donor liver transplantation: does it minimise errors of estimation?. J Clin Exp Hepatol. 2020, 10:1-8. 10.1016\/j.jceh.2019.03.006","journal-title":"J Clin Exp Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2017.10.003","article-title":"Acute and chronic rejection after liver transplantation: what a clinician needs to know","volume":"7","author":"Choudhary NS","year":"2017","unstructured":"Choudhary NS, Saigal S, Bansal RK, Saraf N, Gautam D, Soin AS. Acute and chronic rejection after liver transplantation: what a clinician needs to know. J Clin Exp Hepatol. 2017, 7:358-66. 10.1016\/j.jceh.2017.10.003","journal-title":"J Clin Exp Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jmd2.12053","article-title":"Domino liver transplantation for select metabolic disorders: expanding the living donor pool","volume":"48","author":"Celik N","year":"2019","unstructured":"Celik N, Squires JE, Soltys K, et al.. Domino liver transplantation for select metabolic disorders: expanding the living donor pool. JIMD Rep. 2019, 48:83-9. 10.1002\/jmd2.12053","journal-title":"JIMD Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/238349-domino-liver-transplantation-anesthetic-considerations-for-a-patient-with-maple-syrup-urine-disease-and-type-i-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T06:50:02Z","timestamp":1724827802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/238349-domino-liver-transplantation-anesthetic-considerations-for-a-patient-with-maple-syrup-urine-disease-and-type-i-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.67983","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,27]]}}}